References H-R

HANANIA, N. A., MULLEROVA, H., LOCANTORE, N. W., VESTBO, J., WATKINS, M. L., WOUTERS, E. F., RENNARD, S. I. & SHARAFKHANEH, A. (2011) Determinants of Depression in the ECLIPSE Chronic Obstructive Pulmonary Disease Cohort. Am J Respir Crit Care Med, 183, 604-611.

HART, J. E., LADEN, F., EISEN, E. A., SMITH, T. J. & GARSHICK, E. (2009) Chronic obstructive pulmonary disease mortality in railroad workers. Occup Environ Med, 66, 221-6.

HAY, J. G., STONE, P., CARTER, J., CHURCH, S., EYRE-BROOK, A., PEARSON, M. G., WOODCOCK, A. A. & CALVERLEY, P. M. (1992) Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J, 5, 659-64.

HERNANDES, N. A., WOUTERS, E. F., MEIJER, K., ANNEGARN, J., PITTA, F. & SPRUIT, M. A. (2011) Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J, 38, 261-7.

HIGGINS, B. G., POWELL, R. M., COOPER, S. & TATTERSFIELD, A. E. (1991) Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J, 4, 415-20.

HILL, K., PATMAN, S. & BROOKS, D. (2010) Effect of airway clearance techniques in patients experiencing an acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Chron Respir Dis, 7, 9-17.

HOLE, D. J., WATT, G. C., DAVEY-SMITH, G., HART, C. L., GILLIS, C. R. & HAWTHORNE, V. M. (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ, 313, 711-5; discussion 715-6.

HOLGUIN, F., FOLCH, E., REDD, S. C. & MANNINO, D. M. (2005) Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest, 128, 2005-11.

HOLLAND, A. E. & BUTTON, B. M. (2006) Is there a role for airway clearance techniques in chronic obstructive pulmonary disease? Chron Respir Dis, 3, 83-91.

HOLVERDA, S., RIETEMA, H., BOGAARD, H. J., WESTERHOF, N., POSTMUS, P. E., BOONSTRA, A. & VONK-NOORDEGRAAF, A. (2008) Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD. Pulm Pharmacol Ther, 21, 558-64.

HOMIK, J., CRANNEY, A., SHEA, B., TUGWELL, P., WELLS, G., ADACHI, R. & SUAREZ-ALMAZOR, M. (2000) Bisphosphonates for steroid induced osteoporosis. Cochrane Database Syst Rev, CD001347.

HOOGENDOORN, M., FEENSTRA, T. L., HOOGENVEEN, R. T., AL, M. & MOLKEN, M. R. (2010a) Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis, 5, 435-44.

HOOGENDOORN, M., FEENSTRA, T. L., HOOGENVEEN, R. T. & RUTTEN-VAN MOLKEN, M. P. (2010b) Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax, 65, 711-8.

HOOGENDOORN, M., HOOGENVEEN, R. T., RUTTEN-VAN MOLKEN, M. P., VESTBO, J. & FEENSTRA, T. L. (2010c) Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J, 37, 508-15.

HU, G., ZHOU, Y., TIAN, J., YAO, W., LI, J., LI, B. & RAN, P. (2010) Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest, 138, 20-31.

HUGHES, J. R., STEAD, L. F. & LANCASTER, T. (2000) Anxiolytics for smoking cessation. Cochrane Database Syst Rev, CD002849.

HUGHES, J. R., STEAD, L. F. & LANCASTER, T. (2007) Antidepressants for smoking cessation. Cochrane Database Syst Rev, CD000031.

HUNG, W. W., WISNIVESKY, J. P., SIU, A. L. & ROSS, J. S. (2009) Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 180, 134-7.

HUNTER, C. J., BRIGHTLING, C. E., WOLTMANN, G., WARDLAW, A. J. & PAVORD, I. D. (2002) A comparison of the validity of different diagnostic tests in adults with asthma. Chest, 121, 1051-7.

HURST, J. R., VESTBO, J., ANZUETO, A., LOCANTORE, N., MULLEROVA, H., TAL-SINGER, R., MILLER, B., LOMAS, D. A., AGUSTI, A., MACNEE, W., CALVERLEY, P., RENNARD, S., WOUTERS, E. F. & WEDZICHA, J. A. (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med, 363, 1128-38.

HYNNINEN, M. J., BJERKE, N., PALLESEN, S., BAKKE, P. S. & NORDHUS, I. H. (2010) A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med, 104, 986-94.

INCALZI, R. A., GEMMA, A., MARRA, C., CAPPARELLA, O., FUSO, L. & CARBONIN, P. (1997) Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest, 112, 1506-13.

ISADA CM & STOLLER JK (1994) Chronic bronchitis: the role of antibiotics. IN NIEDERMAN MS, SAROSI GA & GLASSROTH J (Eds.) Respiratory Infections: a Scientific Basis for Management. London, WB Saunders.

IVERSEN, K. K., KJAERGAARD, J., AKKAN, D., KOBER, L., TORP-PEDERSEN, C., HASSAGER, C., VESTBO, J. & KJOLLER, E. (2008) Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med, 264, 361-9.

JANDA, S., PARK, K., FITZGERALD, J. M., ETMINAN, M. & SWISTON, J. (2009) Statins in COPD: a systematic review. Chest, 136, 734-43.

JENKINS, C. R., CELLI, B., ANDERSON, J. A., FERGUSON, G. T., JONES, P. W., VESTBO, J., YATES, J. C. & CALVERLEY, P. M. (2012) Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J, 39, 38-45.

JENKINS, S. C., HEATON, R. W., FULTON, T. J. & MOXHAM, J. (1987) Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest, 91, 804-7.

JENNINGS, A. L., DAVIES, A. N., HIGGINS, J. P., GIBBS, J. S. & BROADLEY, K. E. (2002) A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57, 939-44.

JENNINGS, J. H., DIGIOVINE, B., OBEID, D. & FRANK, C. (2009) The association between depressive symptoms and acute exacerbations of COPD. Lung, 187, 128-35.

JONES, A., FAY, J. K., BURR, M., STONE, M., HOOD, K. & ROBERTS, G. (2002) Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003537.

JONES, A. P. & ROWE, B. H. (1998) Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database Syst Rev, CD000045.

JONES, A. T. & EVANS, T. W. (1997) NO: COPD and beyond. Thorax, 52 Suppl 3, S16-21.

JONES, D. A. & PETERS, T. J. (1992) Caring for elderly dependents: effects on the carers' quality of life. Age Ageing, 21, 421-8.

JONES, P. W., ANDERSON, J. A., CALVERLEY, P. M., CELLI, B. R., FERGUSON, G. T., JENKINS, C., YATES, J. C., VESTBO, J. & SPENCER, M. D. (2011a) Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res, 12, 71.

JONES, P. W., HARDING, G., BERRY, P., WIKLUND, I., CHEN, W. H. & KLINE LEIDY, N. (2009) Development and first validation of the COPD Assessment Test. Eur Respir J, 34, 648-54.

JONES, P. W., MAHLER, D. A., GALE, R., OWEN, R. & KRAMER, B. (2011b) Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. Respir Med, 105, 892-9.

JORDAN, N., LEE, T. A., VALENSTEIN, M., PIRRAGLIA, P. A. & WEISS, K. B. (2009) Effect of depression care on outcomes in COPD patients with depression. Chest, 135, 626-32.

JOSEPH, A. M., NORMAN, S. M., FERRY, L. H., PROCHAZKA, A. V., WESTMAN, E. C., STEELE, B. G., SHERMAN, S. E., CLEVELAND, M., ANTONUCCIO, D. O., HARTMAN, N. & MCGOVERN, P. G. (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med, 335, 1792-8.

KARDOS, P., WENCKER, M., GLAAB, T. & VOGELMEIER, C. (2007) Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 175, 144-9.

KARNER, C. & CATES, C. J. (2011) Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD008532.

KATON, W., LIN, E. H. & KROENKE, K. (2007) The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry, 29, 147-55.

KELLY, C. A. & GIBSON, G. J. (1988) Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax, 43, 335-6.

KENNEDY, A., REEVES, D., BOWER, P., LEE, V., MIDDLETON, E., RICHARDSON, G., GARDNER, C., GATELY, C. & ROGERS, A. (2007) The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. J Epidemiol Community Health, 61, 254-61.

KESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B. & WEITZENBLUM, E. (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 159, 158-64.

KESTEN, S., JARA, M., WENTWORTH, C. & LANES, S. (2006) Pooled clinical trial analysis of tiotropium safety. Chest, 130, 1695-703.

KLIBER, A., LYND, L. D. & SIN, D. D. (2010) The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease. Respir Res, 11, 56.

KOBAYASHI, M., NASUHARA, Y., BETSUYAKU, T., SHIBUYA, E., TANINO, Y., TANINO, M., TAKAMURA, K., NAGAI, K., HOSOKAWA, T. & NISHIMURA, M. (2004) Effect of low-dose theophylline on airway inflammation in COPD. Respirology, 9, 249-54.

KOLODZIEJ, M. A., JENSEN, L., ROWE, B. & SIN, D. (2007) Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Eur Respir J, 30, 293-306.

KONECNY, T., SOMERS, K., ORBAN, M., KOSHINO, Y., LENNON, R. J., SCANLON, P. D. & RIHAL, C. S. (2010) Interactions between COPD and outcomes after percutaneous coronary intervention. Chest, 138, 621-7.

KONG, G. K., BELMAN, M. J. & WEINGARTEN, S. (1997) Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. Chest, 111, 89-94.

KORNMANN, O., DAHL, R., CENTANNI, S., DOGRA, A., OWEN, R., LASSEN, C. & KRAMER, B. (2011) Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison. Eur Respir J, 37, 273-9.

KOTTKE, T. E., BATTISTA, R. N., DEFRIESE, G. H. & BREKKE, M. L. (1988) Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA, 259, 2883-9.

KRAMER, N., MEYER, T. J., MEHARG, J., CECE, R. D. & HILL, N. S. (1995) Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med, 151, 1799-806.

KUNIK, M. E., BRAUN, U., STANLEY, M. A., WRISTERS, K., MOLINARI, V., STOEBNER, D. & ORENGO, C. A. (2001) One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med, 31, 717-23.

KUNIK, M. E., ROUNDY, K., VEAZEY, C., SOUCHEK, J., RICHARDSON, P., WRAY, N. P. & STANLEY, M. A. (2005) Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 127, 1205-11.

LACASSE, Y., BEAUDOIN, L., ROUSSEAU, L. & MALTAIS, F. (2004) Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis, 61, 140-7.

LACASSE, Y., GOLDSTEIN, R., LASSERSON, T. J. & MARTIN, S. (2006) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003793.

LANCASTER, T. & STEAD, L. (2004) Physician advice for smoking cessation. Cochrane Database Syst Rev, CD000165.

LANCASTER, T., STEAD, L., SILAGY, C. & SOWDEN, A. (2000) Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ, 321, 355-8.

LAROS, C. D., GELISSEN, H. J., BERGSTEIN, P. G., VAN DEN BOSCH, J. M., VANDERSCHUEREN, R. G., WESTERMANN, C. J. & KNAEPEN, P. J. (1986) Bullectomy for giant bullae in emphysema. J Thorac Cardiovasc Surg, 91, 63-70.

LAURIN, C., LABRECQUE, M., DUPUIS, G., BACON, S. L., CARTIER, A. & LAVOIE, K. L. (2009) Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med, 71, 667-74.

LAURIN, C., LAVOIE, K. L., BACON, S. L., DUPUIS, G., LACOSTE, G., CARTIER, A. & LABRECQUE, M. (2007) Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest, 132, 148-55.

LEE, P. N. & FRY, J. S. (2010) Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med, 8, 84.

LEE, T. A., PICKARD, A. S., AU, D. H., BARTLE, B. & WEISS, K. B. (2008) Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med, 149, 380-90.

LEE, T. A., WILKE, C., JOO, M., STROUPE, K. T., KRISHNAN, J. A., SCHUMOCK, G. T. & PICKARD, A. S. (2009) Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med, 169, 1403-10.

LINDENAUER, P. K., PEKOW, P. S., LAHTI, M. C., LEE, Y., BENJAMIN, E. M. & ROTHBERG, M. B. (2010) Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA, 303, 2359-67.

LIVERMORE, N., SHARPE, L. & MCKENZIE, D. (2010) Prevention of panic attacks and panic disorder in COPD. Eur Respir J, 35, 557-63.

LORIG, K. R., SOBEL, D. S., STEWART, A. L., BROWN, B. W., JR., BANDURA, A., RITTER, P., GONZALEZ, V. M., LAURENT, D. D. & HOLMAN, H. R. (1999) Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care, 37, 5-14.

LOTTERS, F., VAN TOL, B., KWAKKEL, G. & GOSSELINK, R. (2002) Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J, 20, 570-6.

LUNG HEALTH STUDY RESEARCH GROUP (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med, 343, 1902-9.

MACFARLANE, J. T., COLVILLE, A., GUION, A., MACFARLANE, R. M. & ROSE, D. H. (1993) Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet, 341, 511-4.

MACLAY, J. D., MCALLISTER, D. A., MILLS, N. L., PATERSON, F. P., LUDLAM, C. A., DROST, E. M., NEWBY, D. E. & MACNEE, W. (2009) Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 180, 513-20.

MAHMARIAN, J. J., MOYE, L. A., NASSER, G. A., NAGUEH, S. F., BLOOM, M. F., BENOWITZ, N. L., VERANI, M. S., BYRD, W. G. & PRATT, C. M. (1997) Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol, 30, 125-30.

MALTAIS, F., BOURBEAU, J., SHAPIRO, S., LACASSE, Y., PERRAULT, H., BALTZAN, M., HERNANDEZ, P., ROULEAU, M., JULIEN, M., PARENTEAU, S., PARADIS, B., LEVY, R. D., CAMP, P., LECOURS, R., AUDET, R., HUTTON, B., PENROD, J. R., PICARD, D. & BERNARD, S. (2008) Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med, 149, 869-78.

MALTAIS, F., CELLI, B., CASABURI, R., PORSZASZ, J., JARRETA, D., SEOANE, B. & CARACTA, C. (2011) Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med, 105, 580-7.

MALTAIS, F., CELLI, B., CASABURI, R., PORSZASZ, J., JARRETA, D., SEOANE, B. & CARACTA, C. (2011) Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med, 105, 580-7.

MARIN, J. M., SORIANO, J. B., CARRIZO, S. J., BOLDOVA, A. & CELLI, B. R. (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med, 182, 325-31.

MARSH, S. E., TRAVERS, J., WEATHERALL, M., WILLIAMS, M. V., ALDINGTON, S., SHIRTCLIFFE, P. M., HANSELL, A. L., NOWITZ, M. R., MCNAUGHTON, A. A., SORIANO, J. B. & BEASLEY, R. W. (2008) Proportional classifications of COPD phenotypes. Thorax, 63, 761-7.

MATHERS, C., VOS, T. & STEVENSON, C. (1999) The Burden of Disease and Injury in Australia, Canberra, Australian Institute of Health and Welfare.

MATHESON, M. C., BENKE, G., RAVEN, J., SIM, M. R., KROMHOUT, H., VERMEULEN, R., JOHNS, D. P., WALTERS, E. H. & ABRAMSON, M. J. (2005) Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax, 60, 645-51.

MCCORD, J. & BORZAK, S. (1998) Multifocal atrial tachycardia. Chest, 113, 203-9.

MCDONALD, C. F., CROCKETT, A. J. & YOUNG, I. H. (2005) Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med J Aust, 182, 621-6.

MCEVOY, R. D., PIERCE, R. J., HILLMAN, D., ESTERMAN, A., ELLIS, E. E., CATCHESIDE, P. G., O'DONOGHUE, F. J., BARNES, D. J. & GRUNSTEIN, R. R. (2009) Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax, 64, 561-6.

MCKAY, S. E., HOWIE, C. A., THOMSON, A. H., WHITING, B. & ADDIS, G. J. (1993) Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. Thorax, 48, 227-32.

MCKEOUGH, Z. J., LEUNG, R. W. & ALISON, J. A. (2011) Shuttle walk tests as outcome measures: Are two incremental shuttle walk tests and two endurance shuttle walk tests necessary? Am J Phys Med Rehabil, 90, 35-9.

MCLEAN, S., NURMATOV, U., LIU, J. L., PAGLIARI, C., CAR, J. & SHEIKH, A. (2011) Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD007718.

MCNICHOLAS, W. T. (2009) Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med, 180, 692-700.

MEDICAL RESEARCH COUNCIL WORKING PARTY (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet, 1, 681-6.

MEECHAM JONES, D. J., PAUL, E. A., JONES, P. W. & WEDZICHA, J. A. (1995) Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med, 152, 538-44.

MEHRAN, R. J. & DESLAURIERS, J. (1995) Indications for surgery and patient work-up for bullectomy. Chest Surg Clin N Am, 5, 717-34.

MEINE, T. J., PATEL, M. R., WASHAM, J. B., PAPPAS, P. A. & JOLLIS, J. G. (2005) Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol, 95, 976-8.

MELANI, A. S., BONAVIA, M., CILENTI, V., CINTI, C., LODI, M., MARTUCCI, P., SERRA, M., SCICHILONE, N., SESTINI, P., ALIANI, M. & NERI, M. (2011) Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med, 105, 930-8.

MEYER, T. J. & HILL, N. S. (1994) Noninvasive positive pressure ventilation to treat respiratory failure. Ann Intern Med, 120, 760-70.

MILLER, M. R., HANKINSON, J., BRUSASCO, V., BURGOS, F., CASABURI, R., COATES, A., CRAPO, R., ENRIGHT, P., VAN DER GRINTEN, C. P., GUSTAFSSON, P., JENSEN, R., JOHNSON, D. C., MACINTYRE, N., MCKAY, R., NAVAJAS, D., PEDERSEN, O. F., PELLEGRINO, R., VIEGI, G. & WANGER, J. (2005) Standardisation of spirometry. Eur Respir J, 26, 319-38.

MIMS AUSTRALIA PTY LTD (2008) MIMS Online. Sydney, Health Communication Network.

MINISTRY OF HEALTH (2010) Mortality and Demographic Data 2007. Wellington, Ministry of Health.

MIRAVITLLES, M., ESPINOSA, C., FERNANDEZ-LASO, E., MARTOS, J. A., MALDONADO, J. A. & GALLEGO, M. (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest, 116, 40-6.

MIRAVITLLES, M., FERRER, M., PONT, A., ZALACAIN, R., ALVAREZ-SALA, J. L., MASA, F., VEREA, H., MURIO, C., ROS, F. & VIDAL, R. (2004) Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax, 59, 387-95.

MITTE, K. (2005) A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord, 88, 27-45.

MOAYYEDI, P., CONGLETON, J., PAGE, R. L., PEARSON, S. B. & MUERS, M. F. (1995) Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. Thorax, 50, 834-7.

MOGULKOC, N., KARAKURT, S., ISALSKA, B., BAYINDIR, U., CELIKEL, T., KORTEN, V. & COLPAN, N. (1999) Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med, 160, 349-53.

MOLFINO, N. A. & ZHANG, P. (2006) A meta-analysis on the efficacy of oral theophylline in patients with stable COPD. Int J Chron Obstruct Pulmon Dis, 1, 261-6.

MONTERO, M., DOMINGUEZ, M., OROZCO-LEVI, M., SALVADO, M. & KNOBEL, H. (2009) Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study. Infection, 37, 16-9.

MOORE, R. P., BERLOWITZ, D. J., DENEHY, L., PRETTO, J. J., BRAZZALE, D. J., SHARPE, K., JACKSON, B. & MCDONALD, C. F. (2011) A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax, 66, 32-7.

MORGAN, M. D. L., CALVERLEY, P. M. A. & CLARK, C. J. (2001) Pulmonary rehabilitation. British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation. Thorax, 56, 827-34.

MOXHAM, J. (1988) Aminophylline and the respiratory muscles: an alternative view. Clin Chest Med, 9, 325-36.

MURCIANO, D., AUCLAIR, M. H., PARIENTE, R. & AUBIER, M. (1989) A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med, 320, 1521-5.

MURPHY, T. F., SETHI, S., KLINGMAN, K. L., BRUEGGEMANN, A. B. & DOERN, G. V. (1999) Simultaneous respiratory tract colonization by multiple strains of nontypeable haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis, 180, 404-9.

NANNINI, L., CATES, C. J., LASSERSON, T. J. & POOLE, P. (2004) Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003794.

NATIONAL EMPHYSEMA TREATMENT TRIAL RESEARCH, G. (2001) Patients at High Risk of Death after Lung-Volume-Reduction Surgery. N Engl J Med, 345, 1075-1083.

NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL (1998) A guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra, NHMRC.

NATIONAL HEART LUNG AND BLOOD INSTITUTE (1998) Morbidity and Mortality: Chartbook on Cardiovascular, Lung, and Blood Diseases [2004 edition available http://www.nhlbi.nih.gov/resources/docs/cht-book.htm]. Bethesda, MD, US Department of Health and Institutes of Health.

NETT (1999) Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg, 118, 518-28.

NG, T. P., NITI, M., TAN, W. C., CAO, Z., ONG, K. C. & ENG, P. (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med, 167, 60-7.

NHLBI/WHO WORKSHOP REPORT (April 2001) Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD): Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda, MD, National Institutes of Health - National Heart, Lung and Blood Institute.

NHS CENTRE FOR REVIEWS AND DISSEMINATION (2003) Inhaler devices for the management of asthma and COPD. Effective Healthcare: Bulletin on the Effectiveness of Health Service Interventions for Decision Makers, 8, 1-12.

NICHOL, K. L., MARGOLIS, K. L., WUORENMA, J. & VON STERNBERG, T. (1994) The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med, 331, 778-84.

NICI, L., DONNER, C., WOUTERS, E., ZUWALLACK, R., AMBROSINO, N., BOURBEAU, J., CARONE, M., CELLI, B., ENGELEN, M., FAHY, B., GARVEY, C., GOLDSTEIN, R., GOSSELINK, R., LAREAU, S., MACINTYRE, N., MALTAIS, F., MORGAN, M., O'DONNELL, D., PREFAULT, C., REARDON, J., ROCHESTER, C., SCHOLS, A., SINGH, S. & TROOSTERS, T. (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med, 173, 1390-413.

NITENBERG, A. & ANTONY, I. (1999) Effects of nicotine gum on coronary vasomotor responses during sympathetic stimulation in patients with coronary artery stenosis. J Cardiovasc Pharmacol, 34, 694-9.

NOCTURNAL OXYGEN THERAPY TRIAL GROUP (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med, 93, 391-8.

NONOYAMA, M. L., BROOKS, D., LACASSE, Y., GUYATT, G. H. & GOLDSTEIN, R. S. (2007) Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD005372.

O'BRIEN, K., GEDDES, E. L., REID, W. D., BROOKS, D. & CROWE, J. (2008) Inspiratory muscle training compared with other rehabilitation interventions in chronic obstructive pulmonary disease: a systematic review update. J Cardiopulm Rehabil Prev, 28, 128-41.

O'DONNELL, D. E., REVILL, S. M. & WEBB, K. A. (2001) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164, 770-7.

O'DRISCOLL, B. R. (2008) Short burst oxygen therapy in patients with COPD. Monaldi Arch Chest Dis, 69, 70-4.

O'NEILL, B., MAHON, J. M. & BRADLEY, J. (2006) Short-burst oxygen therapy in chronic obstructive pulmonary disease. Respir Med, 100, 1129-38.

OGALE, S. S., LEE, T. A., AU, D. H., BOUDREAU, D. M. & SULLIVAN, S. D. (2010) Cardiovascular events associated with ipratropium bromide in COPD. Chest, 137, 13-9.

OLENCHOCK, B. A., FONAROW, G. G., PAN, W., HERNANDEZ, A. & CANNON, C. P. (2009) Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes. Am J Cardiol, 103, 295-300.

OMACHI, T. A., KATZ, P. P., YELIN, E. H., GREGORICH, S. E., IRIBARREN, C., BLANC, P. D. & EISNER, M. D. (2009) Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med, 122, 778 e9-15.

ORENS, J. B., ESTENNE, M., ARCASOY, S., CONTE, J. V., CORRIS, P., EGAN, J. J., EGAN, T., KESHAVJEE, S., KNOOP, C., KOTLOFF, R., MARTINEZ, F. J., NATHAN, S., PALMER, S., PATTERSON, A., SINGER, L., SNELL, G., STUDER, S., VACHIERY, J. L. & GLANVILLE, A. R. (2006) International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 25, 745-55.

OSBORNE, R. H., JORDAN, J. E. & ROGERS, A. (2008) A critical look at the role of self-management for people with arthritis and other chronic diseases. Nat Clin Pract Rheumatol, 4, 224-5.

PARKES, G., GREENHALGH, T., GRIFFIN, M. & DENT, R. (2008) Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ, 336, 598-600.

PATEL, I. S., SEEMUNGAL, T. A., WILKS, M., LLOYD-OWEN, S. J., DONALDSON, G. C. & WEDZICHA, J. A. (2002) Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax, 57, 759-64.

PAUWELS, R. A., LOFDAHL, C. G., LAITINEN, L. A., SCHOUTEN, J. P., POSTMA, D. S., PRIDE, N. B. & OHLSSON, S. V. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med, 340, 1948-53.

PELLEGRINO, R., VIEGI, G., BRUSASCO, V., CRAPO, R. O., BURGOS, F., CASABURI, R., COATES, A., VAN DER GRINTEN, C. P., GUSTAFSSON, P., HANKINSON, J., JENSEN, R., JOHNSON, D. C., MACINTYRE, N., MCKAY, R., MILLER, M. R., NAVAJAS, D., PEDERSEN, O. F. & WANGER, J. (2005) Interpretative strategies for lung function tests. Eur Respir J, 26, 948-68.

PEPIN, V., SAEY, D., WHITTOM, F., LEBLANC, P. & MALTAIS, F. (2005) Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 172, 1517-22.

PETERS, M. J. & MORGAN, L. C. (2002) The pharmacotherapy of smoking cessation. Med J Aust, 176, 486-90.

PETO, R., SPEIZER, F. E., COCHRANE, A. L., MOORE, F., FLETCHER, C. M., TINKER, C. M., HIGGINS, I. T., GRAY, R. G., RICHARDS, S. M., GILLILAND, J. & NORMAN-SMITH, B. (1983) The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am Rev Respir Dis, 128, 491-500.

PEYTREMANN-BRIDEVAUX, I., STAEGER, P., BRIDEVAUX, P. O., GHALI, W. A. & BURNAND, B. (2008) Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med, 121, 433-443 e4.

PHILLIPSON, E. A. & BOWES, G. (1986) Control of breathing during sleep. IN CHERNIACK, N. S. & WIDDICOMBE, J. G. (Eds.) Handbook of Physiology. The Respiratory System. Vol II. Control of Breathing. Bethesda, MD, American Physiological Society.

PITTA, F., TROOSTERS, T., SPRUIT, M. A., PROBST, V. S., DECRAMER, M. & GOSSELINK, R. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 171, 972-7.

PLANT, P. K., OWEN, J. L. & ELLIOTT, M. W. (2000) Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet, 355, 1931-5.

POLLACK, M. H., KRADIN, R., OTTO, M. W., WORTHINGTON, J., GOULD, R., SABATINO, S. A. & ROSENBAUM, J. F. (1996) Prevalence of panic in patients referred for pulmonary function testing at a major medical center. Am J Psychiatry, 153, 110-3.

POMERLEAU, C. S., POMERLEAU, O. F., NAMENEK, R. J. & MEHRINGER, A. M. (2000) Short-term weight gain in abstaining women smokers. J Subst Abuse Treat, 18, 339-42.

POOLE, P. & BLACK, P. N. (2010) Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD001287.

POOLE, P. J., CHACKO, E., WOOD-BAKER, R. W. & CATES, C. J. (2006) Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD002733.

POSTMA, D. S., PETERS, I., STEENHUIS, E. J. & SLUITER, H. J. (1988) Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J, 1, 22-6.

POSTMA, D. S., STEENHUIS, E. J., VAN DER WEELE, L. T. & SLUITER, H. J. (1985) Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur J Respir Dis, 67, 56-64.

POULAIN, M., DURAND, F., PALOMBA, B., CEUGNIET, F., DESPLAN, J., VARRAY, A. & PREFAUT, C. (2003) 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest, 123, 1401-7.

PUHAN, M., SCHARPLATZ, M., TROOSTERS, T., WALTERS, E. H. & STEURER, J. (2009a) Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD005305.

PUHAN, M., VOLLENWEIDER, D., LATSHANG, T., STEURER, J. & STEURER-STEY, C. (2008) Exacerbations of chronic obstructive pulmonary disease: When are antibiotics indicated? A systematic review. Respir Res, 9, 81.

PUHAN, M. A., GARCIA-AYMERICH, J., FREY, M., TER RIET, G., ANTO, J. M., AGUSTI, A. G., GOMEZ, F. P., RODRIGUEZ-ROISIN, R., MOONS, K. G., KESSELS, A. G. & HELD, U. (2009b) Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet, 374, 704-11.

PUHAN, M. A., VOLLENWEIDER, D., LATSHANG, T., STEURER, J. & STEURER-STEY, C. (2007) Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res, 8, 30.

RABE, K. F., BATEMAN, E. D., O'DONNELL, D., WITTE, S., BREDENBROKER, D. & BETHKE, T. D. (2005) Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 366, 563-71.

RAM, F. S., JONES, P. W., CASTRO, A. A., DE BRITO, J. A., ATALLAH, A. N., LACASSE, Y., MAZZINI, R., GOLDSTEIN, R. & CENDON, S. (2002) Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003902.

RAM, F. S., PICOT, J., LIGHTOWLER, J. & WEDZICHA, J. A. (2004) Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD004104.

RAM, F. S., RODRIGUEZ-ROISIN, R., GRANADOS-NAVARRETE, A., GARCIA-AYMERICH, J. & BARNES, N. C. (2006) Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD004403.

RAM, F. S. & SESTINI, P. (2003) Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Thorax, 58, 580-4.

RAM, F. S. & WEDZICHA, J. A. (2002) Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD000238.

RAM, F. S., WEDZICHA, J. A., WRIGHT, J. & GREENSTONE, M. (2003) Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD003573.

REA, H., KENEALY, T., ADAIR, J., ROBINSON, E. & SHERIDAN, N. (2011) Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis, 6, 527-32.

RENNARD, S. I., SCHACHTER, N., STREK, M., RICKARD, K. & AMIT, O. (2006) Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest, 129, 56-66.

REVILL, S. M., WILLIAMS, J., SEWELL, L., COLLIER, R. & SINGH, S. J. (2009) Within-day repeatability of the endurance shuttle walk test. Physiotherapy, 95, 140-3.

RICE, K. L., DEWAN, N., BLOOMFIELD, H. E., GRILL, J., SCHULT, T. M., NELSON, D. B., KUMARI, S., THOMAS, M., GEIST, L. J., BEANER, C., CALDWELL, M. & NIEWOEHNER, D. E. (2010) Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med, 182, 890-6.

RICE, V. H. & STEAD, L. F. (2004) Nursing interventions for smoking cessation. Cochrane Database Syst Rev, CD001188.

RIES, A. L., BAULDOFF, G. S., CARLIN, B. W., CASABURI, R., EMERY, C. F., MAHLER, D. A., MAKE, B., ROCHESTER, C. L., ZUWALLACK, R. & HERRERIAS, C. (2007) Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest, 131, 4S-42S.

RIES, A. L., KAPLAN, R. M., LIMBERG, T. M. & PREWITT, L. M. (1995) Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med, 122, 823-32.

RIES, A. L., MAKE, B. J., LEE, S. M., KRASNA, M. J., BARTELS, M., CROUCH, R. & FISHMAN, A. P. (2005) The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest, 128, 3799-809.

RIETEMA, H., HOLVERDA, S., BOGAARD, H. J., MARCUS, J. T., SMIT, H. J., WESTERHOF, N., POSTMUS, P. E., BOONSTRA, A. & VONK-NOORDEGRAAF, A. (2008) Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur Respir J, 31, 759-64.

RIVERA-FERNANDEZ, R., NAVARRETE-NAVARRO, P., FERNANDEZ-MONDEJAR, E., RODRIGUEZ-ELVIRA, M., GUERRERO-LOPEZ, F. & VAZQUEZ-MATA, G. (2006) Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med, 34, 2317-24.

RIZKALLAH, J., MAN, S. F. & SIN, D. D. (2009) Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest, 135, 786-93.

RODRIGO, G. J., CASTRO-RODRIGUEZ, J. A. & PLAZA, V. (2009) Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: a systematic review. Chest, 136, 1029-38.

RODRIGUEZ, E., FERRER, J., MARTI, S., ZOCK, J. P., PLANA, E. & MORELL, F. (2008) Impact of occupational exposure on severity of COPD. Chest, 134, 1237-43.

ROEDE, B. M., BRESSER, P., BINDELS, P. J., KOK, A., PRINS, M., TER RIET, G., GESKUS, R. B., HERINGS, R. M. & PRINS, J. M. (2008) Antibiotic treatment is associated with reduced risk of a subsequent exacerbation in obstructive lung disease: an historical population based cohort study. Thorax, 63, 968-73.

ROEHRS, T., MERRION, M., PEDROSI, B., STEPANSKI, E., ZORICK, F. & ROTH, T. (1995) Neuropsychological function in obstructive sleep apnea syndrome (OSAS) compared to chronic obstructive pulmonary disease (COPD). Sleep, 18, 382-8.

ROSSI, A., GOTTFRIED, S. B., HIGGS, B. D., ZOCCHI, L., GRASSINO, A. & MILIC-EMILI, J. (1985) Respiratory mechanics in mechanically ventilated patients with respiratory failure. J Appl Physiol, 58, 1849-58.

RUTTEN, F. H., ZUITHOFF, N. P., HAK, E., GROBBEE, D. E. & HOES, A. W. (2010) Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med, 170, 880-7.